澳洋健康(002172) - 2018 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2018 was ¥1,173,333,019.27, a decrease of 6.04% compared to ¥1,248,789,207.89 in the same period last year[9] - Net profit attributable to shareholders was ¥22,113,615.68, down 62.82% from ¥59,484,864.25 year-on-year[9] - The net profit after deducting non-recurring gains and losses was ¥1,696,606.41, a significant decline of 96.84% compared to ¥53,719,547.43 in the previous year[9] - Basic earnings per share decreased to ¥0.030, down 62.96% from ¥0.081 in the previous year[9] - The total profit decreased by 72.38% compared to the same period last year, mainly due to a decrease in the gross margin of viscose[18] - Net profit decreased by 82.07% compared to the same period last year, primarily due to a decrease in the gross margin of viscose[18] - The company expects the net profit attributable to shareholders for the first half of 2018 to range from a decrease of 48.25% to an increase of 0.39% compared to the same period last year[23] Cash Flow and Assets - The net cash flow from operating activities improved to -¥89,546,837.28, a 54.92% increase from -¥198,651,725.24 in the same period last year[9] - The net cash flow from operating activities increased by 54.92% compared to the same period last year, mainly due to an increase in cash received from sales of goods and services[18] - The net cash inflow from investment activities increased by 100% compared to the same period last year, primarily due to no occurrences in the previous year[18] - The cash and cash equivalents balance at the end of the period decreased by 31.73% compared to the same period last year, mainly due to a decrease in net cash increase[20] Assets and Shareholder Equity - Total assets at the end of the reporting period were ¥6,196,640,972.15, reflecting a 12.60% increase from ¥5,503,310,461.29 at the end of the previous year[9] - The net assets attributable to shareholders increased by 1.99% to ¥1,527,596,937.69 from ¥1,497,828,047.23 at the end of the previous year[9] Shareholder Information - The top shareholder, Aoyang Group Co., Ltd., holds 48.97% of the shares, with 120,047,752 shares pledged[13] Inventory and Prepaid Accounts - Prepaid accounts increased by 47.48% compared to the beginning of the period, mainly due to prepayments for the Funning Phase III project and the hospital Phase III project[18] - Inventory increased by 32.98% compared to the beginning of the period, primarily due to a lack of active procurement of viscose products downstream, leading to increased inventory[18] Financial Expenses - The financial expenses increased by 159.17% compared to the same period last year, mainly due to an increase in loans[18] Corporate Actions - The company plans to terminate the stock option and restricted stock incentive plan due to market conditions and stock price fluctuations[21]